Lumasiran for treating primary hyperoxaluria type 1. NICE highly specialised technologies guidance 25

National Institute for Health and Care Excellence (NICE)
Record ID 32018014139
English
Details
Project Status: Completed
URL for project: https://www.nice.org.uk/guidance/hst25
Year Published: 2023
URL for published report: https://www.nice.org.uk/guidance/hst25
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England
MeSH Terms
  • Hyperoxaluria, Primary
  • Hyperoxaluria
  • RNA, Small Interfering
  • Renal Agents
Contact
Organisation Name: National Institute for Health and Care Excellence
Contact Address: Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.